The Full Story
中文One company's whole story on the stock market, told in chapters around one long price chart, with the turning points marked.
-
Summit Therapeutics: One Man, One Drug and a $500 Million Check
How a failed British antibiotics company became a $27.1 billion bet on a drug from China, controlled by one investor, and why the FDA said no.
-
The Rise and Reversals of Super Micro, an Unlikely Star of the AI Boom
From an $8 IPO in 2007 to the AI boom: how Super Micro twice soared on demand and twice fell on questions about its books and controls, told from the record.